PCN28 COST SAVINGS WITH FERRIC CARBOXYMALTOSE THROUGH ITS IMPACT ON ERYTHROPOÏESIS-STIMULATING AGENTS AND BLOOD TRANSFUSION IN CHEMOTHERAPY-INDUCED ANEMIA OF BREAST AND GASTROINTESTINAL CANCER: FRENCH HEALTH CARE PAYER PERSPECTIVE

03 medical and health sciences 0302 clinical medicine Health Policy Public Health, Environmental and Occupational Health
DOI: 10.1016/j.jval.2011.02.886 Publication Date: 2011-05-08T00:19:50Z